Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain

Journal of Physiology

Volumn 574, Issue 1, 2006, Pages 85-93

  Ramamurthy, Santosh ^a   Ronnett, Gabriele V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; LEPTIN;

BIOSENSOR; BRAIN FUNCTION; BRAIN NERVE CELL; CELL ENERGY; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; ENERGY BALANCE; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; FEEDING BEHAVIOR; GENETIC CONSERVATION; GLIA CELL; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; HYPOXIA; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; STARVATION; TISSUE DISTRIBUTION; ANOREXIA; BRAIN; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEEDING; NERVE CELL;

ANIMALS; BRAIN; ENERGY METABOLISM; FATTY ACIDS; FEEDING BEHAVIOR; GLUCOSE; HOMEOSTASIS; HUMANS; PROTEIN KINASES;

EID: 33745199458     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.110122     Document Type: Review

References (74)

1. Almeida A, Almeida J, Bolanos JP & Moncada S (2001). Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A 98, 15294-15299.
2. Almeida A, Moncada S & Bolanos JP (2004). Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6, 45-51.
3. 2+/ calmodulin-dependent protein kinase kinase β. J Biol Chem 273, 31880-31889.
4. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D & Small CJ (2004). AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279, 12005-12008.
5. Blazquez C, Geelen MJ, Velasco G & Guzman M (2001). The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett 489, 149-153.
6. Blazquez C, Woods A, De Ceballos ML, Carling D & Guzman M (1999). The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes. J Neurochem 73, 1674-1682.
7. Carling D (2004). The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29, 18-24.
8. Cox SE, Pearce B & Munday MR (1997). AMP-activated protein kinase in astrocytes. Biochem Soc Trans 25, S583.
9. Culmsee C, Monnig J, Kemp BE & Mattson MP (2001). AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17, 45-58.
10. C. FEBS Lett 377, 421-425.
11. Gao G, Widmer J, Stapleton D, Teh T, Cox T, Kemp BE & Witters LA (1995). Catalytic subunits of the porcine and rat 5′-AMP-activated protein kinase are members of the SNF1 protein kinase family. Biochim Biophys Acta 1266, 73-82.
12. Garcia-Gil M, Pesi R, Perna S, Allegrini S, Giannecchini M, Camici M & Tozzi MG (2003). 5′-Aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 117, 811-820.
13. Hallows KR (2005). Emerging role of AMP-activated protein kinase in coupling membrane transport to cellular metabolism. Curr Opin Nephrol Hypertens 14, 464-471.
14. Hardie DG (2004 a). The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117, 5479-5487.
15. Hardie DG (2004 b). AMP-activated protein kinase: A master switch in glucose and lipid metabolism. Rev Endocr Metab Disord 5, 119-125.
16. Hardie DG (2005). New roles for the LKB1→AMPK pathway. Curr Opin Cell Biol 17, 167-173.
17. Hardie DG & Carling D (1997). The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246, 259-273.
18. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR & Hardie DG (2003). Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2, 28.
19. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D & Hardie DG (1996). Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271, 27879-27887.
20. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG & Hardie DG (2005). Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2, 9-19.
21. Hayashi T, Hirshman MF, Kurth EJ, Winder WW & Goodyear LJ (1998). Evidence for 5′-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369-1373.
22. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280, 29060-29066.
23. Johnston MV (2005). Excitotoxicity in perinatal brain injury. Brain Pathol 15, 234-240.
24. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ & Thompson CB (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-293.
25. Jung JE, Lee J, Ha J, Kim SS, Cho YH, Baik HH & Kang I (2004). 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-κB in mouse Neuro 2a neuroblastoma cells. Neurosci Lett 354, 197-200.
26. Kahn BB, Alquier T, Carling D & Hardie DG (2005). AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1, 15-25.
27. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, Van Denderen B, Jennings IG, Iseli T, Michell BJ & Witters LA (2003). AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31, 162-168.
28. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH & Ronnett GV (2004 a). C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 279, 19970-19976.
29. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK & Lee KU (2004 b). Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10, 727-733.
30. Kirkham TC (2005). Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16, 297-313.
31. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB & Korbonits M (2005). Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 280, 25196-25201.
32. Landree LE, Hanlon AL, Strong DW, Rumbaugh G, Miller IM, Thupari JN, Connolly EC, Huganir RL, Richardson C, Witters LA, Kuhajda FP & Ronnett GV (2004). C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. J Biol Chem 279, 3817-3827.
33. Lane MD, Hu Z, Cha SH, Dai Y, Wolfgang M & Sidhaye A (2005). Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. Biochem Soc Trans 33, 1063-1067.
34. Lee K, Li B, Xi X, Suh Y & Martin RJ (2005). Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 146, 3-10.
35. Leff T (2003). AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31, 224-227.
36. Levin BE (2001). Glucosensing neurons do more than just sense glucose. Int J Obes Relat Metab Disord 25 (Suppl. 5), S68-S72.
37. Levin BE, Routh VH, Kang L, Sanders NM & Dunn-Meynell AA (2004). Neuronal glucosensing: What do we know after 50 years? Diabetes 53, 2521-2528.
38. Lewen A, Matz P & Chan PH (2000). Free radical pathways in CNS injury. J Neurotrauma 17, 871-890.
39. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD & Kuhajda FP (2000). Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381.
40. Luo Z, Saha AK, Xiang X & Ruderman NB (2005). AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26, 69-76.
41. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van Den Berghe G, Carling D & Hue L (2000). Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10, 1247-1255.
42. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ & Sherwin RS (2004). Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 53, 1953-1958.
43. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J & Ronnett GV (2005). Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280, 20493-20502.
44. Merrill GF, Kurth EJ, Hardie DG & Winder WW (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273, E1107-E1112.
45. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ & Kahn BB (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574.
46. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D & Kahn BB (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
47. Moore F & Brophy PJ (1994). Regulation of acetyl-CoA carboxylase (ACC) by ATP depletion in developing oligodendrocytes mimics the action of AMP-activated protein kinase (AMPK). Biochem Soc Trans 22, 416S.
48. Mu J, Brozinick J, Joseph T, Valladares O, Bucan M & Birnbaum MJ (2001). A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7, 1085-1094.
49. Namkoong C, Kim MS, Jang PG, Han SM, Park HS, Koh EH, Lee WJ, Kim JY, Park IS, Park JY & Lee KU (2005). Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 54, 63-68.
50. Obici S, Feng Z, Arduini A, Conti R & Rossetti L (2003). Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9, 756-761.
51. Pertsch M, Duncan GE, Stumpf WE & Pilgrim C (1988). A histochemical study of the regional distribution in the rat brain of enzymatic activity hydrolyzing glucose-and 2-deoxyglucose-6-phosphate. Histochemistry 88, 257-262.
52. Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R & Tomlinson I (2000). In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol 192, 203-206.
53. Ruderman NB, Saha AK & Kraegen EW (2003). Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144, 5166-5171.
54. Ruderman NB, Saha AK, Vavvas D & Witters LA (1999). Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276, E1-E18.
55. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ & Young LH (2004). AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114, 495-503.
56. 2+/ calmodulin-dependent protein kinase kinases in the adult rat brain. Brain Res Mol Brain Res 54, 311-315.
57. Sakamoto K, McCarthy A, Smith D, Green KA, Hardie GD, Ashworth A & Alessi DR (2005). Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24, 1810-1820.
58. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA & Cantley LC (2004). The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101, 3329-3335.
59. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M & Cantley LC (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646.
60. Spanswick D, Smith MA, Groppi VE, Logan SD & Ashford ML (1997). Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390, 521-525.
61. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3, 757-758.
62. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA & Kemp BE (1996). Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271, 611-614.
63. Stein SC, Woods A, Jones NA, Davison MD & Carling D (2000). The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345, 437-443.
64. Thupari JN, Landree LE, Ronnett GV & Kuhajda FP (2002). C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci U S A 99, 9498-9502.
65. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE & Bartlett PF (1999). Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72, 1707-1716.
66. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA & Ruderman NB (1997). Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272, 13255-13261.
67. Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W & Routh VH (2004). The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53, 1959-1965.
68. Williams G, Bing C, Cai XJ, Harrold JA, King PJ & Liu XH (2001). The hypothalamus and the control of energy homeostasis: Different circuits, different purposes. Physiol Behav 74, 683-701.
69. Winder WW & Hardie DG (1996). Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270, E299-E304.
70. Witters LA, Kemp BE & Means AR (2006). Chutes and Ladders: The search for protein kinases that act on AMPK. Trends Biochem Sci 31, 13-16.
71. 2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2, 21-33.
72. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M & Carling D (2003). LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004-2008.
73. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB & Kadowaki T (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295.
74. Almeida A, Almeida J, Bolanos JP & Moncada S (2001). Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A 98, 15294-15299.